LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE)
In: Lupus Science and Medicine, Jg. 10 (2023-07-01), Heft Suppl 1
Online
academicJournal
Zugriff:
Titel: |
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE)
|
---|---|
Autor/in / Beteiligte Person: | Kaneko, Yuko ; Okada, Masato ; Finzel, Stephanie ; Shen, Nan ; Vishneva, Elena ; Sun, Lingyun ; Rojkovich, Bernadette ; Hoi, Alberta ; Lee, Shin-Seok ; Leszczyński, Piotr ; Dai, Lie ; Wojciechowski, Rafal ; Wei, Cheng-Chung ; Romanowska-Prochnicka, Katarzyna ; Kaneko, Hiroshi ; Ignatenko, Stanislav ; Gordienko, Alexander ; Hernandez, Josefina ; Levin, Nancy ; Narongroeknawin, Pongthorn ; Ciferska, Hanna ; Kodera, Masanari ; Joung Liang Lan ; Tarr, Tunde ; Yi Hsing Chen ; Koolvisoot, Ajchara ; Zotkin, Eugeny ; Berta Paula magallares ; Sengupta, Tirtha ; Sips, Carole ; Oliver, Stephan |
Link: | |
Zeitschrift: | Lupus Science and Medicine, Jg. 10 (2023-07-01), Heft Suppl 1 |
Veröffentlichung: | BMJ Publishing Group, 2023 |
Medientyp: | academicJournal |
ISSN: | 2053-8790 (print) |
DOI: | 10.1136/lupus-2023-KCR.21 |
Schlagwort: |
|
Sonstiges: |
|